Letrozole 112809-51-5
Product: Letrozole
Appearance: off white crystalline powder
Assay: 99.80% min.
CAS No.:112809-51-5
M.F.: C17H11N5
M.W.: 285.31
Package: 0.5kg/bag or according to requirements
Usage: used as API in Treatment of breast disease.
Place of Origin: China (mainland)
Delivery Detail: for prompt shipment
|
Name: Letrozole
|
MF: C17H11N5
|
Grade Standard: Medicine Grade
|
|
Purity : 99.80% min
|
CAS No. 112809-51-5
|
Type: Antineoplastic
|
|
M.W.: 285.31
|
Place of Origin: China (mainland)
|
Packaging: 0.5kg/aluminium foil bag
|
Specifications: In-house Standard
General Info: Letrozole is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women.
Letrozole's intermediates:
112809-25-3 17201-43-3